Literature DB >> 102610

Chloroquine retinopathy in the rhesus monkey.

A R Rosenthal, H Kolb, D Bergsma, D Huxsoll, J L Hopkins.   

Abstract

Chloroquine was administered intramuscularly 5 days a week to rhesus monkeys for as long as 4 1/2 years. No clinical, fluorescein angiographic, or electrophysiological evidence of retinal damage was observed. Yet chloroquine/chloroquine byproduct analysis of the ocular tissues revealed an enormous binding capacity of the pigmented tissues of the eye (choroid plus RPE, ciliary body, and iris) with eventual accumulation observed in the retina. Despite the normal ophthalmic appearance and function, extensive pathological changes occurred in the retinas and choroids of these experimental monkeys. The chloroquine caused an initial dramatic effect on the ganglion cells, with the photoreceptors affected shortly thereafter. Patching degeneration of the ganglion cells and photoreceptors then progressed over several years, with the choroid and pigment epithelium ultimately deteriorating as well.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102610

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  54 in total

Review 1.  Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations.

Authors:  Sonia Guha; Erin E Coffey; Wennan Lu; Jason C Lim; Jonathan M Beckel; Alan M Laties; Kathleen Boesze-Battaglia; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

2.  2-Phenyl-APB-144-Induced Retinal Pigment Epithelium Degeneration and Its Underlying Mechanisms.

Authors:  Shin-ichiro Hirai; Hiroaki Kurashima; Daisuke Nakamura; Tomoko Komatsu; Yuki Yasuda; Sayo Habashita-Obata; Sanae Ichikawa; Osamu Katsuta; Takao Iwawaki; Kenji Kohno
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-27       Impact factor: 2.671

3.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

4.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

5.  Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings.

Authors:  A H Rahi; J L Hungerford; A I Ahmed
Journal:  Br J Ophthalmol       Date:  1986-05       Impact factor: 4.638

6.  Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam.

Authors:  H Kuhn; P Keller; E Kovács; A Steiger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

7.  Optical coherence tomography based microangiography findings in hydroxychloroquine toxicity.

Authors:  Jason Kam; Qinqin Zhang; Jason Lin; Jin Liu; Ruikang K Wang; Kasra Rezaei
Journal:  Quant Imaging Med Surg       Date:  2016-04

8.  Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report.

Authors:  Xiaoyun Ma; Liang Yan; Linping He; Dongyi He; Hao Lu
Journal:  Diagn Pathol       Date:  2010-03-29       Impact factor: 2.644

9.  ERG findings in patients using hydroxychloroquine.

Authors:  Radouil T Tzekov; Alexandra Serrato; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

10.  Pathogenesis and reversibility of retinopathy induced by 1,4-bis (4-aminophenoxy)-2-phenylbenzene (2-phenyl-APB-144) in pigmented rats.

Authors:  K P Lee; R Valentine
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.